Jo A Wick
Overview
Explore the profile of Jo A Wick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clark L, Shergina E, Machado N, Scheuermann T, Sultana N, Polineni D, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2446018.
PMID: 39602123
Importance: The ranks of academic physicians do not reflect the diversity of the US population. To create a diverse and effective medical workforce, it is important to know the extent...
2.
Scheuermann T, Clark L, Sultana N, Machado N, Shergina E, Polineni D, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2445143.
PMID: 39541115
Importance: Poor retention may be associated with lack of faculty diversity in academic medicine. Objective: To examine differences in faculty retention by gender, degree type, and race and ethnicity using...
3.
Shi X, Wick J, Christifano D, Carlson S, Brown A, Mudaranthakam D, et al.
Contemp Clin Trials
. 2024 Jul;
144:107633.
PMID: 39013543
Background: Early preterm birth (ePTB) - born before 34 weeks of gestation - poses a significant public health challenge. Two randomized trials indicated an ePTB reduction among pregnant women receiving...
4.
Shi X, Wick J, Martin R, Beall J, Silbergleit R, Rockswold G, et al.
Stat Med
. 2024 Jun;
43(19):3649-3663.
PMID: 38885949
Emergency medical diseases (EMDs) are the leading cause of death worldwide. A time-to-death analysis is needed to accurately identify the risks and describe the pattern of an EMD because the...
5.
Shi X, Mudaranthakam D, Wick J, Streeter D, Thompson J, Streeter N, et al.
Contemp Clin Trials Commun
. 2024 Feb;
38:101281.
PMID: 38419809
Introduction: Slow patient accrual in cancer clinical trials is always a concern. In 2021, the University of Kansas Comprehensive Cancer Center (KUCC), an NCI-designated comprehensive cancer center, implemented the Curated...
6.
Gao G, Wick J, Brown A, Barohn R, Gajewski B
Commun Stat Case Stud Data Anal Appl
. 2023 Sep;
9(3):252-269.
PMID: 37692073
The PAIN-CONTRoLS trial compared four medications in treating Cryptogenic sensory polyneuropathy. The primary outcome was a utility function that combined two outcomes, patients' pain score reduction and patients' quit rate....
7.
Duan J, Gajewski B, Sen P, Wick J
J Biopharm Stat
. 2023 Apr;
34(2):276-295.
PMID: 37016726
Detection of safety signals based on multiple comparisons of adverse events (AEs) between two treatments in a clinical trial involves evaluations requiring multiplicity adjustment. A Bayesian hierarchical mixture model is...
8.
Zhang C, Mayo M, Wick J, Gajewski B
Pharm Stat
. 2021 Jan;
20(3):573-596.
PMID: 33463906
Patients with different characteristics (e.g., biomarkers, risk factors) may have different responses to the same medicine. Personalized medicine clinical studies that are designed to identify patient subgroup treatment efficacies can...
9.
Richter K, Clark L, Wick J, Cruvinel E, Durham D, Shaw P, et al.
N Engl J Med
. 2020 Nov;
383(22):2148-2157.
PMID: 33252871
Background: In 2000, a landmark study showed that women who graduated from U.S. medical schools from 1979 through 1997 were less likely than their male counterparts to be promoted to...
10.
Mudaranthakam D, Phadnis M, Krebill R, Clark L, Wick J, Thompson J, et al.
Contemp Clin Trials Commun
. 2020 Jun;
18:100579.
PMID: 32510004
Early phase clinical trials are the first step in testing new medications and therapeutics developed by clinical and biomedical investigators. These trials aim to find a safe dose of a...